<DOC>
	<DOCNO>NCT01092273</DOCNO>
	<brief_summary>Bimatoprost show provide effective IOP lower patient race . Conversely , travoprost show effective black patient Caucasians study . However , Noecker et al 2004 compare bimatoprost travoprost African-Americans glaucoma OHT , find bimatoprost likely travoprost achieve target pressure 3 month . These racial difference efficacy medication warrant investigation . The investigator study aim compare IOP-lowering efficacy bimatoprost travoprost Egyptian population primary open-angle glaucoma ( OAG ) ocular hypertension ( OHT ) .</brief_summary>
	<brief_title>Bimatoprost Versus Travoprost Cairo University</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Glaucoma Ocular Hypertension Any ocular disease medication may raise intraocular pressure .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Glaucoma Ocular Hypertension</keyword>
</DOC>